Article info

Download PDFPDF
Addition of aprepitant improves acute emesis control in children and adolescents receiving induction chemotherapy for acute myeloid leukaemia: a randomised, open-label trial

Authors

  1. Correspondence to Dr Sameer Bakhshi, Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, Delhi, India; sambakh{at}hotmail.com
View Full Text

Citation

Sharma A, Ganguly S, C SK, et al
Addition of aprepitant improves acute emesis control in children and adolescents receiving induction chemotherapy for acute myeloid leukaemia: a randomised, open-label trial

Publication history

  • Received July 22, 2020
  • Revision received September 22, 2020
  • Accepted October 5, 2020
  • First published October 29, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.